|
|
|
|
Vol. 62, Issue 5, 1061-1067, November 2002
Division of Pharmacology/Neurobiology, Biozentrum of the University
of Basel, Basel, Switzerland
Cytochrome P450 CYP1A1 is expressed in most tissues. In brain and
kidney, its function remains unclear because its enzymatic activity is
barely measurable. Here, we report on the localization of CYP1A1 in the
cytosol of kidney and brain, as revealed by immunoblotting with
anti-CYP1A1 antibodies and by 7-ethoxyresorufin deethylation (EROD).
Hematin (8 µM) added in vitro to cytosol increased the EROD-activity
10-fold in brain olfactory bulb and 7-fold in kidney, presumably by
reconstitution of apocytochrome. Succinylacetone, an inhibitor of heme
biosynthesis, increased the ratio of cytosolic to microsomal EROD
activity of transiently expressed CYP1A1 in COS-1 cells from 1:1 to
nearly 6:1. This indicates a strong decrease of microsomal activity
with increasing succinylacetone concentration. CYP1A1 activities
correlated with CYP1A1 protein assessed by immunoblotting. We conclude
that the availability of heme is a limiting factor of P450 function in
extrahepatic tissue. Our data further suggest that reduced availability
of heme limits the incorporation of P450s into brain endoplasmic
reticulum. These observations are important when assessing the function
of P450s in extrahepatic tissue.
This article has been cited by other articles:
![]() |
M. Gehlhaus, N. Schmitt, B. Volk, and R. P. Meyer Antiepileptic Drugs Affect Neuronal Androgen Signaling via a Cytochrome P450-Dependent Pathway J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 550 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chernova, P. Nicotera, and A. G. Smith Heme Deficiency Is Associated with Senescence and Causes Suppression of N-Methyl-D-aspartate Receptor Subunits Expression in Primary Cortical Neurons Mol. Pharmacol., March 1, 2006; 69(3): 697 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Korashy and A. O. S. El-Kadi Regulatory Mechanisms Modulating the Expression of Cytochrome P450 1A1 Gene by Heavy Metals Toxicol. Sci., November 1, 2005; 88(1): 39 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bandiera, S. Weidlich, V. Harth, P. Broede, Y. Ko, and T. Friedberg Proteasomal Degradation of Human CYP1B1: Effect of the Asn453Ser Polymorphism on the Post-Translational Regulation of CYP1B1 Expression Mol. Pharmacol., February 1, 2005; 67(2): 435 - 443. [Abstract] [Full Text] [PDF] |
||||